Serum proteome analysis in patients with rheumatoid arthritis receiving therapy with etanercept, a chimeric tumor necrosis factor-alpha receptor-Reference-Cited by-同舟云学术

Serum proteome analysis in patients with rheumatoid arthritis receiving therapy with etanercept, a chimeric tumor necrosis factor-alpha receptor

Published:2012-09-25 Issue:5 Volume:15 Page:486-495
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Yanagida Mitsuaki¹,Jung Giman²,Tanaka Yoshinori²,Sone Saburo³,Fujishiro Maki¹,Ikeda Keigo,Nozawa Kazuhisa⁴,Kaneko Hiroshi⁵,Takasaki Yoshinari⁴,Ogawa Hideoki¹,Takamori Kenji¹,Sekigawa Iwao

Affiliation:

1. Institute for Environmental and Gender Specific Medicine; Juntendo University Graduate School of Medicine; Chiba; Japan

2. New Frontiers Research Laboratories; Toray Industries, Inc.; Kanagawa; Japan

3. Head Office; Toray Industries, Inc.; Tokyo; Japan

4. Department of Internal Medicine and Rheumatology; Juntendo University School of Medicine; Tokyo; Japan

5. Department of Rheumatology; Kohnodai Hospital; National Center for Global Health and Medicine; Chiba; Japan

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1756-185X.2012.01816.x/fullpdf

Reference32 articles.

1. Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease;Maini;Immunol Rev,1995

2. Preliminary results of early clinical trials with the fully human anti-TNFalpha monoclonal antibody D2E7;Kempeni;Ann Rheum Dis,1999

3. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists;Mohler;J Immunol,1993

4. The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody;Mihara;Expert Opin Biol Ther,2005

5. CTLA4Ig: a novel inhibitor of costimulation;Dall'Era;Lupus,2004

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining the proteomic landscape of rheumatoid arthritis: progress and prospective clinical applications;Expert Review of Proteomics;2017-05-02

2. Comparative proteomics in alkaptonuria provides insights into inflammation and oxidative stress;The International Journal of Biochemistry & Cell Biology;2016-12

3. Haptoglobin-α1, -α2, vitamin D-binding protein and apolipoprotein C-III as predictors of etanercept drug response in rheumatoid arthritis;Arthritis Research & Therapy;2015-03-06

4. Periodontal and Serum Protein Profiles in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitor Adalimumab;Journal of Periodontology;2014-11

5. Drugs, Trials and Pathogenesis: Will Connecting these Help us Understand SLE?;Current Rheumatology Reviews;2014-01-31